Skip to main content
. 2017 Aug 7;8(52):89566–89579. doi: 10.18632/oncotarget.20023

Figure 6. Inhibition of PKC sensitizes cells to killing by HXR9.

Figure 6

PKC was inhibited using Ro31-8220, reducing the IC50 of HXR9 to 5 μM for K562 cells, and to 10.7 μM for HL-60 cells.